For weight management, FDA labeling and Endocrine Society guidelines recommend evaluating whether patients achieve at least 5% weight loss after approximately 12 weeks on the maintenance dosea benchmark that requires accurate baseline and follow-up measurements
Some preclinical research suggests GLP-1 receptors may exist in various tissues, potentially including reproductive organs, though the clinical significance of semaglutide binding to these receptors regarding fertility remains unclear and unestablished
Tirzepatide is sometimes referred to as the next step after GLP-1 treatments, making patients think its a GLP-2 medication
Moreover, the proportion of patients achieving their personalized HbA1c target levels increased at each subsequent time point
A Narrative Review of BPC-157 for Musculoskeletal Healing." Sports Medicine and Health Science
The appetite-boosting effects of GHRP-6 may be relevant for some research uses, while Ipamorelins more selective GH-releasing effects without major appetite boost may be preferred in other contexts
